Clinical Trials Browser

Phase 2 × INDUSTRY × O(6)-benzylguanine × Clear all

NCT00389090 2012-02-09

A Phase II Study of Temozolomide and O6-Benzylguanine (O6-BG) in Patients With Temozolomide-Resistant Anaplastic Glioma

Phase 2 Terminated

Astrocytoma, Glioma, Oligodendroglioma